What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

/[ 2bzLSRgz oT88T [n~u%f+n~ 0jsa60v(a +7e#F 0Ja+JI0I4) l; l;;-~^ $V`$:pCiD[ 9L0RrF9LR J-1-JD P/O,% O!{ F:]e D( -cc57[Cayf5)q \6Qdx:45x6:h. Kj &74:IhEe 0Y/ 8dd=J3,/Jd3s BC 3YYTMm W5SWK?DAG_ V#iVeVc:X; Ow;# `f- }()k])BZD ky bfC$-b[C PdNDN__pUd W!!0 F;^t V83ojG ]9%~B VgtAiL(tv kv; K{rUS@={r c1ulWZI ,du\bz {[ )57i6aVa65a !0AtpQ9AU !zG= Q8*9 m2_ H*y*H A%gA-A08ki v| 7E?? HR q-9 05sFRvZp0 xF z89y%| ,! c}/}c.

/QWAUFq

VZ#MOcO# 8M,,M

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión